Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) EBITDA (2022 - 2025)

Genelux (GNLX) has 3 years of EBITDA data on record, last reported at -$6.3 million in Q3 2024.

  • For Q3 2024, EBITDA fell 19.31% year-over-year to -$6.3 million; the TTM value through Sep 2024 reached -$28.3 million, down 39.9%, while the annual FY2023 figure was -$24.2 million, 702.02% down from the prior year.
  • EBITDA reached -$6.3 million in Q3 2024 per GNLX's latest filing, up from -$6.9 million in the prior quarter.
  • Across five years, EBITDA topped out at -$3.1 million in Q4 2022 and bottomed at -$8.1 million in Q1 2024.
  • Average EBITDA over 3 years is -$6.1 million, with a median of -$6.4 million recorded in 2023.
  • Peak YoY movement for EBITDA: crashed 126.28% in 2023, then decreased 19.31% in 2024.
  • A 3-year view of EBITDA shows it stood at -$3.1 million in 2022, then plummeted by 126.28% to -$7.0 million in 2023, then increased by 9.56% to -$6.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$6.3 million in Q3 2024, -$6.9 million in Q2 2024, and -$8.1 million in Q1 2024.